Skip to content
Review

Comparative Safety and Efficacy of Dual Antiplatelet Therapy Regimens in Flow Diversion for Intracranial Aneurysms: a Systematic Review and Network Meta-Analysis.

Sep 2026 · Clinical Neuroradiology · 0 citations · 50 references
Medicine

TL;DR

Current FD-specific evidence is insufficient to establish superiority, inferiority, or equivalence among clopidogrel-, ticagrelor- and prasugrel-based DAPT regimens across ischemic, hemorrhagic, functional, and survival outcomes.

View source

Similar papers

Review Open access Sep 2026

Dual antiplatelet therapy duration after percutaneous coronary intervention with contemporary drug-eluting stents: A systematic review and network meta-analysis of randomized trials

Shorter DAPT durations (1 & 3 months) were associated with reduced bleeding without evidence of increased ischemic risk compared with the conventional 12-month strategy, suggesting it may represent a pragmatic threshold for DAPT abbreviation.

Admire Hlupeni, Mehran Jalilzadehbinazar, R. J. Liceralde et al. · 0 citations
Review Open access Aug 2026

Cilostazol or clopidogrel? Comparative evidence on bleeding risk, stroke recurrence, and mortality in ischemic stroke – A systematic review and meta-analysis

Ischemic stroke remains a major contributor to global mortality and long-term disability, with antiplatelet therapy representing a fundamental strategy for secondary prevention. Cilostazol and clopidogrel are widely utilized antiplatelet agents; however, existing comparative evidence on their safety and efficacy, parti...

Kadek Kovaleviska Okaniawan, N. Maheswari, Putu Enrico Pramana Okaniawan et al. · 0 citations
Review Open access Sep 2026

THE SAFETY OF ANTIPLATELET REVERSAL PROCEDURES BEFORE EMERGENCY NEUROSURGERY IN PATIENTS WITH RUPTURED ANEURYSMS POST-EMBOLIZATION: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS AND PRIMARY STUDIES

Introduction: Stent-assisted coil embolisation and flow diversion have expanded the endovascular armamentarium for acutely ruptured wide-necked and complex intracranial aneurysms, but these devices oblige dual antiplatelet therapy in patients who have just sustained subarachnoid haemorrhage and frequently require emerg...

Anissa Putri Almira, Yoyok Subagio · 0 citations
Meta-analysis Open access Aug 2026

Catheter-directed thrombolysis versus anticoagulation for intermediate-risk and high-risk pulmonary embolism: a systematic review and meta-analysis

Abstract Background Catheter-directed thrombolysis (CDT) has emerged as a reperfusion strategy for intermediate-risk and high-risk pulmonary embolism (PE), potentially improving thrombus resolution while reducing bleeding risk compared with systemic thrombolysis. However, evidence comparing CDT with anticoagulation alo...

A. Simanjuntak, F. Wijayanto, C. D. Tristan et al. · 0 citations
Aug 2026

Ticagrelor Versus Clopidogrel as Dual Antiplatelet Agents After Flow Diversion With Surface-Modified Stents.

BACKGROUND AND OBJECTIVES Dual antiplatelet therapy (DAPT) is an essential component of medical management after flow diversion. To our knowledge, no studies have compared DAPT regimens using ticagrelor vs clopidogrel in patients undergoing flow diversion with newer generation surface-modified stents. Our study compare...

Joanna M. Roy, B. Musmar, M. Pontarelli et al. · 0 citations
Sep 2026

Direct Oral Anticoagulant Plus Single Versus Dual Antiplatelet Therapy After Carotid Artery Stenting: A Multicenter Propensity-Matched Cohort Study.

BACKGROUND AND OBJECTIVES The optimal antithrombotic therapy after carotid artery stenting (CAS) in patients requiring oral anticoagulation is uncertain; in particular, the safety and effectiveness of combining direct oral anticoagulants (DOACs) with single antiplatelet therapy (SAPT) compared with DOACs combined with...

P. Pekyi-Boateng, C. Sollenberger, Georgios S. Sioutas et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.